Jupiter Neurosciences (NASDAQ: JNS) Enhances Advisory Board for Nugevia™ Longevity Line

April 7, 2026

Expert Analysis Jupiter Neurosciences (NASDAQ: JNS) is strategically expanding its expertise by adding two prominent advisors to the Nugevia™ advisory board. These appointments highlight the company’s commitment to leveraging industry-leading knowledge in pharmacy and wellness distribution to enhance its consumer longevity product line. Such moves often signal a company’s proactive approach to navigating competitive markets. By incorporating diverse expertise into its advisory team, Jupiter Neurosciences (NASDAQ: JNS) positions itself to…

Read More >>